Exploring medical potential of cannabinoids

Evaluating the medicinal use of cannabinoids represents an area of massive untapped potential, especially considering its upcoming legalization in Canada. Currently, a significant proportion of medical cannabis research is based on self-reported use and outcomes, rather than carefully-designed research studies. Here, we aim to better understand the impact of cannabis administration in adults with obesity or tobacco dependence and its potential as an opioid-sparing medicine, using randomized controlled clinical trials. Results of these investigations may potentially drive the development of novel pharmacological approaches for the treatment of these conditions.

Faculty Supervisor:

Bernard Le Foll

Student:

Thomas Murphy

Partner:

Canopy Health Innovations

Discipline:

Pharmacy / Pharmacology

Sector:

Medical devices

University:

Program: